Roberta Giorgione
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study.
Journal: Scientific reports
Published: April 06, 2026
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma.
Journal: Oncology and therapy
Published: August 29, 2025
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study.
Journal: In vivo (Athens, Greece)
Published: August 09, 2025
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies.
Journal: Genes
Published: December 03, 2024
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer.
Journal: Minerva urology and nephrology
Published: September 20, 2022
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice.
Journal: Medical oncology (Northwood, London, England)
Published: April 09, 2022
Occurrence of Dysgeusia in Patients Being Treated for Cancer.
Journal: Nutrition and cancer
Published: February 24, 2022
Systemic Sclerosis Association with Malignancy.
Journal: Clinical reviews in allergy & immunology
Published: February 10, 2022
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study.
Journal: Cancer medicine
Published: November 30, 2021
Last Updated: 09/26/2026